Immunotherapy for Head and Neck Cancer Treatment
1 Visninger
• 07/02/23
0
0
Indlejre
administrator
Abonnenter
Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer